Your browser doesn't support javascript.
loading
Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ≥1% by the USA Food and Drug Administration.
Mountzios, G; Remon, J; Novello, S; Blais, N; Califano, R; Cufer, T; Dingemans, A M; Liu, S V; Peled, N; Pennell, N A; Reck, M; Rolfo, C; Tan, D; Vansteenkiste, J; West, H; Besse, B.
Afiliación
  • Mountzios G; Department of Medical Oncology, Henry Dunant Hospital Center, Athens, Greece. Electronic address: gmountzios@gmail.com.
  • Remon J; Department of Medical Oncology, CIOCC HM Delfos Hospital, Barcelona, Spain.
  • Novello S; Department of Oncology, University of Turin, AOU San Luigi, Orbassano, Italy.
  • Blais N; Centre Hospitalier Universitaire de Montréal, University of Montreal, Montreal, Canada.
  • Califano R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester; Division of Cancer Sciences, University of Manchester, Manchester, UK.
  • Cufer T; University Clinic Golnik, Medical Faculty Ljubljana, Slovenia.
  • Dingemans AM; Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht and Erasmus Medical Center, Rotterdam, The Netherlands.
  • Liu SV; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA.
  • Peled N; Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel.
  • Pennell NA; Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, USA.
  • Reck M; Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.
  • Rolfo C; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, USA.
  • Tan D; Division of Medical Oncology, National Cancer Centre, Singapore.
  • Vansteenkiste J; Respiratory Oncology Unit, University Hospital KU Leuven, Leuven, Belgium.
  • West H; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, USA.
  • Besse B; Cancer Medicine Department, Institut Gustave Roussy, Villejuif; Université Paris-Saclay, Orsay, France.
Ann Oncol ; 30(11): 1686-1688, 2019 11 01.
Article en En | MEDLINE | ID: mdl-31504132
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Antígeno B7-H1 / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Antígeno B7-H1 / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article